AusPAR: Acalabrutinib

Australian Public Assessment Report

AusPAR

AusPAR: Acalabrutinib [PDF, 460.88 KB]

AusPAR: Acalabrutinib [Word, 650.33 KB]

Attachment: Product Information for Acalabrutinib [PDF, 360.35 KB]

Attachment: Product Information for Acalabrutinib [Word, 245.15 KB]

Device/Product Name

Calquence

Active ingredients

Acalabrutinib

AusPAR Date

17 February 2020

Published

10 March 2020

Submission Number

PM-2019-04317-1-6

Submission Type

Extension of indications

Decision

Approved